Delivery Order SPE2DR25D3103-SPE2DR26F9F57
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,443.56 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 ml pens on November 6, 2025, with completion targeted for November 7, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a $7,523.82 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pens. This competitively awarded, non-set-aside contract represents a single delivery order fulfillment with an ultimate completion date of September 24, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its...
- The Defense Logistics Agency awarded a delivery order valued at $1,501.50 to AmerisourceBergen Drug Corp for Trulicity 4.5 mg/0.5 ml pens on October 28, 2025, with completion expected by October 29, 2025. This non-competitive, firm fixed-price delivery order represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier within the federal medical supply chain. The order will be fulfilled from the company's Conshohocken, Pennsylvania location, which serves as the...
- The Defense Logistics Agency awarded a $10,999.90 delivery order to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 ml pens on August 19, 2025, with an ultimate completion date of August 20, 2025. This firm fixed-price contract is not set-aside and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is...
- The Defense Logistics Agency awarded a delivery order valued at $1,466.22 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 mL pens on November 4, 2025, with completion expected by November 5, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and designates AmerisourceBergen's Conshohocken, Pennsylvania facility as the place of performance. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order valued at $1,351.35 to AmerisourceBergen Drug Corp for Trulicity 0.75 mg/0.5 mL pens on July 28, 2025, with completion scheduled for July 29, 2025. This firm fixed-price delivery order, which was competitively awarded without set-aside designation, represents pharmaceutical procurement under the company's larger contract vehicle with DLA. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency awarded a $1,490.03 delivery order to AmerisourceBergen Drug Corp for Trulicity 0.75 mg/0.5 ml pens on September 11, 2025, with completion expected by September 12, 2025. This firm fixed price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The product will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pens valued at $1,772.87 with a completion date of July 31, 2025. This firm fixed-price delivery order represents a non-competitive set-aside award and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement...
- The Defense Logistics Agency awarded a delivery order valued at $4,221.27 to AmerisourceBergen Drug Corp for Trulicity 0.75 mg/0.5 mL pens on September 29, 2025, with completion expected by September 30, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitively awarded contract for pharmaceutical supply to support federal medical procurement needs. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a $1,156.60 delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Trulicity 0.75 mg/0.5 mL pens with a completion date of September 8, 2025. This is a firm fixed-price, non-competitive delivery order placed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical, valued at approximately $1 billion and extending through December 2026. The contract is being performed at the contractor's...
- SPE2DR25D3103Indefinite Delivery Contract
- SPE2DR25D3103-SPE2DR26F9F57Delivery Order
The Defense Logistics Agency awarded a $7,794.59 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 ml pens on November 14, 2025, with an ultimate completion date of November 17, 2025. The contract, which is non-set-aside and competitively awarded, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp, one of the nation's largest pharmaceutical distributors, serves as a critical vendor for federal medical procurement across the Defense Department and related healthcare systems. The underlying IDC vehicle enables the company to supply a comprehensive range of pharmaceuticals and medical commodities—including specialty medications, brand-name and generic drugs, vaccines, and medical devices—to support military healthcare programs globally. This specific delivery order for Trulicity, a diabetes medication, represents a routine pharmaceutical supply execution under the broader prime vendor contract supporting Defense Health Agency, U.S. Coast Guard, and other government healthcare customers.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.8k | 11/14/25 |